A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potential

• Published in: Regulatory toxicology and pharmacology Vol. 122; p. 104892
• Main Authors: Kirkland, David, Kovochich, Michael, More, Sharlee L., Murray, F. Jay, Monnot, Andrew D., Miller, Julie V., Jaeschke, Hartmut, Jacobson-Kram, David, Deore, Milind, Pitchaiyan, Suresh Kumar, Unice, Kenneth, Eichenbaum, Gary
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.06.2021
• Subjects: Acetaminophen; Carcinogenicity; Clastogenicity; Genotoxicity; Mutagenicity; Weight-of-evidence; Clastogenicity; Mutagenicity; Carcinogenicity; Acetaminophen; Weight-of-evidence; Genotoxicity
• ISSN: 0273-2300; 1096-0295
• DOI: 10.1016/j.yrtph.2021.104892

In 2019, the California Office of Environmental Health Hazard Assessment initiated a review of the carcinogenic hazard potential of acetaminophen, including an assessment of its genotoxicity. The objective of this analysis was to inform this review process with a weight-of-evidence assessment of more than 65 acetaminophen genetic toxicology studies that are of widely varying quality and conformance to accepted standards and relevance to humans. In these studies, acetaminophen showed no evidence of induction of point or gene mutations in bacterial and mammalian cell systems or in in vivo studies. In reliable, well-controlled test systems, clastogenic effects were only observed in unstable, p53-deficient cell systems or at toxic and/or excessively high concentrations that adversely affect cellular processes (e.g., mitochondrial respiration) and cause cytotoxicity. Across the studies, there was no clear evidence that acetaminophen causes DNA damage in the absence of toxicity. In well-controlled clinical studies, there was no meaningful evidence of chromosomal damage. Based on this weight-of-evidence assessment, acetaminophen overwhelmingly produces negative results (i.e., is not a genotoxic hazard) in reliable, robust high-weight studies. Its mode of action produces cytotoxic effects before it can induce the stable, genetic damage that would be indicative of a genotoxic or carcinogenic hazard. •Acetaminophen genotoxicity reviewed using weight of evidence approaches.•No induction of gene mutations in bacteria or mammalian cells in vitro or in vivo.•No clastogenicity in robust systems at non-cytotoxic concentrations up to 1 mM in vitro.•No evidence of clastogenicity in well-controlled human studies even at acute overdose.•Does not induce genetic damage indicative of a genotoxic or carcinogenic hazard.